» Articles » PMID: 14521645

APACHE II Predicts Long-term Survival in COPD Patients Admitted to a General Medical Ward

Overview
Publisher Springer
Specialty General Medicine
Date 2003 Oct 3
PMID 14521645
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The Acute Physiology and Chronic Health Evaluation II (APACHE II) was developed to predict intensive-care unit (ICU) resource utilization. This study tested APACHE II's ability to predict long-term survival of patients with chronic obstructive pulmonary disease (COPD) admitted to general medical floors.

Design: We performed a retrospective cohort study of patients admitted for COPD exacerbation outside the ICU. APACHE II scores were calculated by chart review. Mortality was determined by the Social Security Death Index. We tested the association between APACHE II scores and long-term mortality with Cox regression and logistic regression.

Patients: The analysis included 92 patients admitted for COPD exacerbation in two Burlington, Vermont hospitals between January 1995 and June 1996.

Measurements And Main Results: In Cox regression, APACHE II score (hazard ratio [HR] 1.76 for each increase in a 3-level categorization, 95% confidence interval [CI] 1.16 to 2.65) and comorbidity (HR 2.58; 95% CI, 1.36 to 4.88) were associated with long-term mortality (P <.05) in the univariate analysis. After controlling for smoking history, comorbidity, and admission pCO2, APACHE II score was independently associated with long-term mortality (HR 2.19; 95% CI, 1.27 to 3.80). In univariate logistic regression, APACHE II score (odds ratio [OR] 2.31; 95% confidence internal [CI] 1.24 to 4.30) and admission pCO2 (OR 4.18; 95% CI, 1.15 to 15.21) were associated with death at 3 years. After controlling for smoking history, comorbidity, and admission pCO2, APACHE II score was independently associated with death at 3 years (OR 2.62; 95% CI, 1.12 to 6.16).

Conclusion: APACHE II score may be useful in predicting long-term mortality for COPD patients admitted outside the ICU.

Citing Articles

Myeloid Zfhx3 deficiency protects against hypercapnia-induced suppression of host defense against influenza A virus.

Casalino-Matsuda S, Chen F, Gonzalez-Gonzalez F, Matsuda H, Nair A, Abdala-Valencia H JCI Insight. 2024; 9(4).

PMID: 38227369 PMC: 11143927. DOI: 10.1172/jci.insight.170316.


Hypercapnia increases ACE2 expression and pseudo-SARS-CoV-2 entry in bronchial epithelial cells by augmenting cellular cholesterol.

Chen F, Matsuda A, Budinger G, Sporn P, Casalino-Matsuda S Front Immunol. 2023; 14:1251120.

PMID: 37901225 PMC: 10600497. DOI: 10.3389/fimmu.2023.1251120.


Comparison of Risk Models in the Prediction of 30-Day Mortality in Acute Myocardial Infarction-Associated Cardiogenic Shock.

Ranard L, Guber K, Fried J, Takeda K, Kaku Y, Karmpaliotis D Struct Heart. 2023; 6(6):100116.

PMID: 37288128 PMC: 10242577. DOI: 10.1016/j.shj.2022.100116.


Severity of illness scores at presentation predict ICU admission and mortality in COVID-19.

Wilfong E, Lovly C, Gillaspie E, Huang L, Shyr Y, Casey J J Emerg Crit Care Med. 2021; 5.

PMID: 34179689 PMC: 8232354. DOI: 10.21037/jeccm-20-92.


Validation of APACHE II, APACHE III and SAPS II scores in in-hospital and one year mortality prediction in a mixed intensive care unit in Poland: a cohort study.

Czajka S, Ziebinska K, Marczenko K, Posmyk B, Szczepanska A, Krzych L BMC Anesthesiol. 2020; 20(1):296.

PMID: 33267777 PMC: 7709291. DOI: 10.1186/s12871-020-01203-7.


References
1.
Weingarten S, Bolus R, Riedinger M, Maldonado L, Stein S, Ellrodt A . The principle of parsimony: Glasgow Coma Scale score predicts mortality as well as the APACHE II score for stroke patients. Stroke. 1990; 21(9):1280-2. DOI: 10.1161/01.str.21.9.1280. View

2.
. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis. 1987; 136(1):225-44. DOI: 10.1164/ajrccm/136.1.225. View

3.
Berger R, Kelley M . Survival after in-hospital cardiopulmonary arrest of noncritically ill patients. A prospective study. Chest. 1994; 106(3):872-9. DOI: 10.1378/chest.106.3.872. View

4.
Rubin R, Haskal Z, OBrien C, Cope C, Brass C . Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol. 1995; 90(4):556-63. View

5.
. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med. 1995; 152(5 Pt 2):S77-121. View